Insulin-Like Growth Factor-1 Down-Regulates the Phosphorylation of FXYD1 and Rescues Behavioral Deficits in a Mouse Model of Rett Syndrome
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Insulin-Like Growth Factor-1 Down-Regulates the Phosphorylation of FXYD1 and Rescues Behavioral Deficits in a Mouse Model of Rett Syndrome
Authors
Keywords
-
Journal
Frontiers in Neuroscience
Volume 14, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-01-29
DOI
10.3389/fnins.2020.00020
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Correcting deregulated Fxyd1 expression rescues deficits in neuronal arborization and potassium homeostasis in MeCP2 deficient male mice
- (2018) Valerie Matagne et al. BRAIN RESEARCH
- Rett syndrome: insights into genetic, molecular and circuit mechanisms
- (2018) Jacque P. K. Ip et al. NATURE REVIEWS NEUROSCIENCE
- The therapeutic potential of insulin-like growth factor-1 in central nervous system disorders
- (2016) Jesse Costales et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Expression of nuclear Methyl-CpG binding protein 2 (Mecp2) is dependent on neuronal stimulation and application of Insulin-like growth factor 1
- (2016) Daniela Tropea et al. NEUROSCIENCE LETTERS
- Protein kinase C beta II suppresses colorectal cancer by regulating IGF-1 mediated cell survival
- (2016) Catríona M. Dowling et al. Oncotarget
- Insulin-Like Growth Factor 1 and Related Compounds in the Treatment of Childhood-Onset Neurodevelopmental Disorders
- (2016) Cyrus Vahdatpour et al. Frontiers in Neuroscience
- Dysregulation of the IGF-I/PI3K/AKT/mTOR signaling pathway in autism spectrum disorders
- (2014) Jianling Chen et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE
- Functional recovery with recombinant human IGF1 treatment in a mouse model of Rett Syndrome
- (2014) Jorge Castro et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Safety, pharmacokinetics, and preliminary assessment of efficacy of mecasermin (recombinant human IGF-1) for the treatment of Rett syndrome
- (2014) O. S. Khwaja et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Insulin-like growth factor-1 rescues synaptic and motor deficits in a mouse model of autism and developmental delay
- (2013) Ozlem Bozdagi et al. Molecular Autism
- Correcting deregulated Fxyd1 expression ameliorates a behavioral impairment in a mouse model of Rett syndrome
- (2012) Valerie Matagne et al. BRAIN RESEARCH
- PKCη is a negative regulator of AKT inhibiting the IGF-I induced proliferation
- (2012) Galit Shahaf et al. EXPERIMENTAL CELL RESEARCH
- Reduced AKT/mTOR signaling and protein synthesis dysregulation in a Rett syndrome animal model
- (2011) Sara Ricciardi et al. HUMAN MOLECULAR GENETICS
- Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes
- (2010) Hsiao-Tuan Chao et al. NATURE
- Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice
- (2009) Daniela Tropea et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started